Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Change in Receivables (2016 - 2025)

CV Sciences' Change in Receivables history spans 13 years, with the latest figure at -$142000.0 for Q3 2025.

  • For Q3 2025, Change in Receivables rose 35.16% year-over-year to -$142000.0; the TTM value through Sep 2025 reached -$27000.0, up 89.93%, while the annual FY2024 figure was $84000.0, 123.86% up from the prior year.
  • Change in Receivables for Q3 2025 was -$142000.0 at CV Sciences, down from $112000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $610000.0 in Q3 2021 and bottomed at -$1.1 million in Q1 2022.
  • The 5-year median for Change in Receivables is $45000.0 (2023), against an average of -$24947.4.
  • The largest annual shift saw Change in Receivables plummeted 724.06% in 2022 before it skyrocketed 382.61% in 2024.
  • A 5-year view of Change in Receivables shows it stood at $294000.0 in 2021, then tumbled by 63.61% to $107000.0 in 2022, then tumbled by 332.71% to -$249000.0 in 2023, then skyrocketed by 141.37% to $103000.0 in 2024, then plummeted by 237.86% to -$142000.0 in 2025.
  • Per Business Quant, the three most recent readings for CVSI's Change in Receivables are -$142000.0 (Q3 2025), $112000.0 (Q2 2025), and -$100000.0 (Q1 2025).